Neurodegenerative Diseases Drugs Market Expands at 7.2% CAGR and Hit USD 62,786.2 Million by 2026; Biogen and F. Hoffmann-La Roche Ltd Cover More than Half of the Share: Fortune Business Insights

Key Companies Covered in the Neurodegenerative Diseases Drugs Market Research Report Are Novartis AG, Pfizer, Inc., H. Lundbeck A/S, Sanofi, Teva Pharmaceutical Industries Ltd., Orion Pharma, Merck & Co., Inc., UCB S.A, Mitsubishi Tanabe Pharma Corporation, ACADIA Pharmaceuticals Inc. and other key market players.


Pune, Nov. 12, 2020 (GLOBE NEWSWIRE) -- The global neurodegenerative diseases drugs market size is expected to derive growth from the rising prevalence of neurodegenerative diseases especially among the aging population. In 2018, the global market was valued at US$35,497.3 Mn and is projected to be worth US$ 62,786.2 Mn by 2026. At this pace, the global market is estimated to exhibit a healthy CAGR of 7.2% during the forecast duration.  North America market was valued at US$ 18,174.6 Mn and is anticipated to maintain its dominance throughout the forecast years. Neurodegenerative diseases have become more prevalent in the U.S. owing to an increasingly aging population.

Key Industry Developments:

  • In March 2019, Novartis AG announced the FDA approval for Mayzent, an immunomodulator for the treatment of relapsing forms of multiple sclerosis (RMS).
  • In January 2018, Eisai Co., Ltd. collaborated with Biogen for the co-promotion of TECFIDERA, TYSABRI, and AVONEX in Japan.
  • In February 2017, Apitope, a company for drug discovery and development announced positive results from the Phase IIa clinical study of the company’s multiple sclerosis drug candidate named ATX-MS-1467.
  • In February 2019, Acorda Therapeutics launched INBRIJA, an inhalation powder to treat patient with Parkinson’s disease in the U.S.
  • In June 2017, European Commission (EC) granted marketing approval for SPINRAZA, a drug used for treating spinal muscular atrophy.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/neurodegenerative-diseases-drugs-market-100661


Rising Awareness about Neurodegenerative Diseases Fuels Demand for Neurodegenerative Disease Drugs

As per research studies, the prevalence of neurodegenerative diseases among all genders, races, geographical backgrounds, and genders is likely to increase with the rising worldwide population. Rapid lifestyle alterations such as improper sleeping, high-stress levels, and unhealthy eating habits are likely to result in degenerative of nerve cells.

Medical practitioners and physicians are becoming more aware of the neurodegenerative disease treatment, which in turn is enabling neurodegenerative disease drug development. Moreover, several advancements are expected to offer an early diagnosis of these life-threatening diseases.

A recent innovation in neurodegenerative disease drug discovery includes some therapies such as NDMA and dopamine inhibitors. These innovations are anticipated to register progressive growth in the neurodegenerative disease drugs market.


Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/neurodegenerative-diseases-drugs-market-100661


North America Dominates with Rising R&D Investments 

In 2018, the North America market was valued at US$ 18,174.6 Mn and is anticipated to maintain its dominance throughout the forecast years. Neurodegenerative diseases have become more prevalent in the U.S. owing to an increasingly aging population. As per the Alzheimer’s Association, around 5.4 million Americans were suffering from Alzheimer’s in the year 2016. Moreover, this disease is more prevalent among people aged 65 years and above.

Biogen’s Strategic Initiatives Helps the Company to Earn More Profits

In the year 2018, Biogen was dominating the global market. Neurodegenerative disease drug discovery and some important strategic decisions help the company to gain more attention. The launch of a drug called SPINRAZA and increasing sales of another drug called Tecfidera in 2018 helped the company to strengthen its product portfolio.

Also, the company entered into a strategic partnership with F. Hoffmann-La Roche Ltd. to ensure robust distribution of drugs. This, together with the launch of two new drugs called Madopar and Ocrevus helped F. Hoffmann-La Roche Ltd. to gain the second position in the market.


Quick Buy -  Neurodegenerative Diseases Drugs Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100661


Key companies covered in the Neurodegenerative Diseases Drugs Market:

  • Biogen
  • Pfizer, Inc.
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Orion Pharma
  • UCB S.A
  • ACADIA Pharmaceuticals Inc.
  • H. Lundbeck A/S
  • Mitsubishi Tanabe Pharma Corporation
  • Other players


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/neurodegenerative-diseases-drugs-market-100661


Segmentation of the Global Neurodegenerative Diseases Drugs Market:

By Drug Class       

•              Immunomodulator

•              Interferons

•              Decarboxylase Inhibitors

•              Dopamine Agonists

•              Others

By Disease Indication        

•              Multiple Sclerosis

•              Parkinson’s Disease

•              Alzheimer's Disease

•              Spinal Muscular Atrophy (SMA)

•              Others

By Route of Administration             

•              Oral

•              Injection

•              Transdermal

By End User         

•              Hospital Pharmacy

•              Retail Pharmacy

•              Online Pharmacy

By Geography      

•              North America (USA and Canada)

•              Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

•              Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

•              Latin America (Brazil, Mexico and Rest of Latin America)

•              Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)


Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/neurodegenerative-diseases-drugs-market-100661


SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

  • Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
  • Number of procedures and average price of procedures
  • Replacement rate and pricing of capital equipment
  • Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
  • Market & technological trends, new product developments, product pipeline.


Have a Look at Related Reports:

Parkinson’s disease drugs Market Share and Global Trend By Drug Class (Decarboxylase Inhibitors, Dopamine Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitors), Route of Administration (Oral, Injection, Transdermal), Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) & Geography Forecast till 2026

Neurodegenerative Diseases Drugs Market Share and Global Trend By Drug Class (Immunomodulator, Interferons, Decarboxylase Inhibitors, Dopamine Agonists), By Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer's Disease, Spinal Muscular Atrophy (SMA)), By Route of Administration(Oral, Injection, Transdermal) By End User(Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2026

Schizophrenia Drugs Market Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026

Multiple Sclerosis Drugs Market Share and Global Trend By Drug Class (Immunomodulatory, Immunosuppressant, Interferons, Others), By Route of Administration (Oral, Injection), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Stores), and Geography Forecast till 2026

Spinal Muscular Atrophy (SMA) Treatment Market Share & Industry Analysis, By Product (Nusinersen and Onasemnogen Abeparvovec), By Disease Type (Type 1 SMA, Type 2 SMA and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others), and Regional Forecast, 2019-2026


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs


Press Release: https://www.fortunebusinessinsights.com/press-release/neurodegenerative-diseases-drugs-market-9141